Literature DB >> 14907883

Pulmonary artery diastolic pressure: its relationship to pulmonary arteriolar resistance and pulmonary capillary pressure.

N O FOWLER, R N WESTCOTT, R C SCOTT.   

Abstract

Keywords:  ARTERIES, PULMONARY

Mesh:

Year:  1952        PMID: 14907883      PMCID: PMC436384          DOI: 10.1172/JCI102579

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  Anoxia and human pulmonary vascular resistance.

Authors:  R N WESTCOTT; N O FOWLER; R C SCOTT; V D HAUENSTEIN; J McGUIRE
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

2.  The effect of norepinephrine upon pulmonary arteriolar resistance in man.

Authors:  N O FOWLER; R N WESTCOTT; R C SCOTT; J McGUIRE
Journal:  J Clin Invest       Date:  1951-05       Impact factor: 14.808

3.  Some aspects of the pulmonary circulation in normal man and in chronic cardiopulmonary diseases.

Authors:  A COURNAND
Journal:  Circulation       Date:  1950-11       Impact factor: 29.690

4.  Pulmonary circulatory dynamics in health and disease, at rest.

Authors:  L DEXTER
Journal:  Bull New Engl Med Cent       Date:  1949-12

5.  Pulmonary hypertension in chronic pulmonary emphysema.

Authors:  C W BORDEN; R H WILSON; R V EBERT; H S WELLS
Journal:  Am J Med       Date:  1950-06       Impact factor: 4.965

  5 in total
  3 in total

1.  [Venous intermixture and pulmonary circulation in liver cirrhosis].

Authors:  M SCHWAB; R SCHRODER; T DISSMANN; W DISSMANN; P HEIMBURG; U HUTTEMANN; K P SCHUREN
Journal:  Klin Wochenschr       Date:  1963-05-15

2.  Studies of pulmonary hypertension. I. Pulmonary circulatory dynamics in patients with pulmonary emphysema at rest.

Authors:  P N G YU; F W LOVEJOY; H A JOOS; R E NYE; W S MCCANN
Journal:  J Clin Invest       Date:  1953-02       Impact factor: 14.808

3.  Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.

Authors:  N S ASSALI; S KAPLAN; S OIGHENSTEIN; R SUYEMOTO
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.